July 8, 2020 / 2:35 AM / a month ago

BRIEF-Pacira Biosciences Announces Pricing Of $350 Mln Aggregate Principal Amount Of 0.750% Convertible Senior Notes Due 2025

July 7 (Reuters) - Pacira Biosciences Inc:

* PACIRA BIOSCIENCES, INC. ANNOUNCES PRICING OF $350.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 0.750% CONVERTIBLE SENIOR NOTES DUE 2025 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below